ArticleOncotarget2017

CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma.

Tengyue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.